MENU
+Compare
LUCD
Stock ticker: NASDAQ
AS OF
Aug 1 closing price
Price
$1.00
Change
+$0.02 (+2.04%)
Capitalization
42.94M

LUCD Lucid Diagnostics Forecast, Technical & Fundamental Analysis

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma... Show more

LUCD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for LUCD with price predictions
Aug 01, 2025

LUCD's RSI Indicator ascends from oversold territory

The RSI Oscillator for LUCD moved out of oversold territory on August 01, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 30 similar instances when the indicator left oversold territory. In of the 30 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where LUCD advanced for three days, in of 194 cases, the price rose further within the following month. The odds of a continued upward trend are .

LUCD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 24, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on LUCD as a result. In of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for LUCD turned negative on July 30, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 33 similar instances when the indicator turned negative. In of the 33 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LUCD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for LUCD entered a downward trend on July 16, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (35.088) is normal, around the industry mean (24.599). P/E Ratio (0.000) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (15.314) is also within normal values, averaging (43.219).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LUCD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LUCD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
LUCD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

LUCD is expected to report earnings to fall 30.00% to -11 cents per share on August 18

Lucid Diagnostics LUCD Stock Earnings Reports
Q2'25
Est.
$-0.11
Q1'25
Beat
by $0.03
Q4'24
Missed
by $0.02
Q3'24
Beat
by $0.01
Q2'24
Est.
$-0.20
The last earnings report on May 14 showed earnings per share of -15 cents, beating the estimate of -18 cents. With 729.32K shares outstanding, the current market capitalization sits at 42.94M.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
360 Madison Avenue
Phone
+1 917 813-1828
Employees
70
Web
https://www.luciddx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HTCO0.330.01
+2.45%
High-Trend International Group
UGP3.06N/A
N/A
Ultrapar Participacoes SA
TIC11.03-0.06
-0.54%
Acuren Corp
UBER86.91-0.84
-0.96%
Uber Technologies
PERF1.86-0.10
-5.10%
Perfect Corp

LUCD and Stocks

Correlation & Price change

A.I.dvisor tells us that LUCD and NOTV have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LUCD and NOTV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LUCD
1D Price
Change %
LUCD100%
+2.19%
NOTV - LUCD
32%
Poorly correlated
-4.48%
FEMY - LUCD
32%
Poorly correlated
-1.16%
CRL - LUCD
26%
Poorly correlated
-1.61%
INGN - LUCD
26%
Poorly correlated
-1.58%
BWAY - LUCD
25%
Poorly correlated
-1.80%
More